医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

SCI写作之讨论

2018-04-11 MedSci MedSci原创

科研基金
关注

SCI写作之讨论

SCI写作之讨论




评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1649732, encodeId=77611649e320a, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Wed May 02 02:04:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279600, encodeId=d1d412e960058, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:04:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304857, encodeId=5c2730485e85, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Wed Apr 11 20:18:54 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-05-02 xlwang2699

    #SCI写作#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1649732, encodeId=77611649e320a, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Wed May 02 02:04:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279600, encodeId=d1d412e960058, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:04:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304857, encodeId=5c2730485e85, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Wed Apr 11 20:18:54 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-13 chenhongpeng

    #写作#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1649732, encodeId=77611649e320a, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Wed May 02 02:04:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279600, encodeId=d1d412e960058, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:04:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304857, encodeId=5c2730485e85, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Wed Apr 11 20:18:54 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-11 戒馋，懒，贪

    谢谢分享学习了

    0

相关资讯

目标期刊选择

目标期刊选择

研究方案之逻辑链

研究方案之逻辑链研究目标是指从国内外研究现状中分析提炼出需要解决的具体科学问题，提出本研究具体要达到的目的，包括理论和实践的目标，如明确什么样的关系，提示怎样的规律，阐明何种机制等。研究内容是说明“做什么”，需要根据研究目标来确定。具体来讲，就是为了实现目标所设计的3-4个方案概述，这几点之间的逻辑关系和前后顺序要讲清楚。在写作过程中，我们要避免研究内容过多或过散。内容过多，会导致一个研究周期难以

研究基础与工作条件的展示

研究基础与工作条件的展示

审稿意见分析

审稿意见分析

SCI写作之题目与摘要

SCI写作之题目与摘要

标书三剑客 —— 标题、摘要和关键词

标书三剑客 —— 标题、摘要和关键词